Several centres are investing in considerable automation
to allow parallel large-scale expression trials and
parallel crystallization trials (TABLE 1); for example, the
Joint Center for Structural Genomics hopes to be able
to analyse up to 130,000 crystallization experiments per
day33. To ensure optimal use of precious SYNCHROTRON
time, BEAMLINE AUTOMATION is crucial34. In addition, careful
tracking of laboratory results and analyses can be used
to predict better which proteins will be most
successful35; this information might then be fed into the
target-selection process to improve future results.